• Who We Are
    • Vision
    • Our Story
      • Legacy gifts
    • Staff
    • Trustees
    • Contact Us & Directions
    • Financial Documents
  • What We Fund
    • Justice Initiatives
    • Strategic Initiatives
  • Who We Fund
    • Current Grants
    • Past Grants
  • What’s New
  • Publications
  • 30th Anniversary
HomeWhat’s NewCRISPR Genome-Editing Tool Takes Cancer Immunotherapy to the Next Level

What's New

Back

CRISPR Genome-Editing Tool Takes Cancer Immunotherapy to the Next Level

Feb 20, 2017

The latest advance for developing CRISPR, using the powerful genome-editing technique, involves using the technology to build chimeric antigen receptor (CAR) T cells, a type of immunotherapy for cancer.

In a new study published in the journal Nature, Memorial Sloan Kettering Cancer Center’s Michel Sadelain and colleagues show how CRISPR can be used to create CAR T cells with improved performance — packing more punch against tumors in mice.

Read more @ Memorial Sloan Kettering Cancer Center

Back

Connect with The Tow Foundation

Directions & Contact

THE TOW FOUNDATION
50 Locust Avenue, Suite 1
New Canaan, CT 06840-4737

Website Flyleaf Creative and Medium Rare | Photography Richard Freeda